Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Adalimumab × Clear all

Phase

Status

Sponsor Class

OTHER 19 INDUSTRY 17 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Colitis, Ulcerative 1

Interventions

Cisplatin 48 Capecitabine 41 Gemcitabine 33 apatinib 32 Oxaliplatin 31 Cyclophosphamide 31 Radiotherapy 29 Paclitaxel 29 Carboplatin 29 tislelizumab 27 Irinotecan 27 Drug Therapy 26 Docetaxel 26 Fluorouracil 25 Bevacizumab 23 fludarabine 18 Nivolumab 17 pembrolizumab 16 Surgical Procedures, Operative 16 Exercise 16 Metformin 15 S 1 (combination) 14 camrelizumab 13 Radiation 13 Pemetrexed 13 Control Groups 12 anlotinib 11 Vinorelbine 10 Radiotherapy, Intensity-Modulated 10 Leucovorin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed

Colitis, Ulcerative, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡